ArticleTranslational andrology and urology2020

Survival benefit of neoadjuvant chemotherapy in pathologic T2N0 or lower urothelial carcinoma patients: evidence to support the use of neoadjuvant chemotherapy.

Hyeong Dong Yuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.